10 results
8-K
EX-99.1
NMTRQ
9 Meters Biopharma, Inc.
16 May 22
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022
7:07am
licensing discussions. We also anticipate our Phase 2 clinical trial data on vurolenatide for short bowel syndrome will provide a data package
8-K
EX-1.1
e7rsmom1trwc9tr69yo
5 Apr 21
9 Meters Biopharma Announces Proposed Public Offering of Common Stock
4:26pm
8-K
EX-1.1
gey0c9 yyo6
15 Dec 20
9 Meters Biopharma, Inc. Announces Proposed Public Offering of Common Stock
4:25pm
10-K
pplfil1gg4hn9xutp
31 Mar 17
Annual report
12:00am
- Prev
- 1
- Next